Fig. 6From: Generation and clinical potential of functional T lymphocytes from gene-edited pluripotent stem cellsSchematic model of the combination of immunotherapy strategies and gene editing technologies in the PSC-to-T platforms. Based on the unique advantages of PSCs, we can perform gene editing to obtain engineered iPSCs for producing safe, universal and function-enhanced iT cells or iHSPCsBack to article page